Literature DB >> 24917575

Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes.

Tomas Jelenik1, Gilles Séquaris1, Kirti Kaul1, D Margriet Ouwens2, Esther Phielix1, Jörg Kotzka3, Birgit Knebel3, Jürgen Weiß3, Anna Lena Reinbeck1, Linda Janke1, Peter Nowotny1, Hans-Joachim Partke4, Dongyan Zhang5, Gerald I Shulman6, Julia Szendroedi7, Michael Roden8.   

Abstract

Although insulin resistance is known to underlie type 2 diabetes, its role in the development of type 1 diabetes has been gaining increasing interest. In a model of type 1 diabetes, the nonobese diabetic (NOD) mouse, we found that insulin resistance driven by lipid- and glucose-independent mechanisms is already present in the liver of prediabetic mice. Hepatic insulin resistance is associated with a transient rise in mitochondrial respiration followed by increased production of lipid peroxides and c-Jun N-terminal kinase activity. At the onset of diabetes, increased adipose tissue lipolysis promotes myocellular diacylglycerol accumulation. This is paralleled by increased myocellular protein kinase C θ activity and serum fetuin A levels. Muscle mitochondrial oxidative capacity is unchanged at the onset but decreases at later stages of diabetes. In conclusion, hepatic and muscle insulin resistance manifest at different stages and involve distinct cellular mechanisms during the development of diabetes in the NOD mouse.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24917575     DOI: 10.2337/db13-1794

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

2.  Lactosylceramide contributes to mitochondrial dysfunction in diabetes.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jin Yu; Jarryd A Keffler; Christopher J Clarke; An O Van Laer; Catalin F Baicu; Michael R Zile; Tatyana I Gudz
Journal:  J Lipid Res       Date:  2016-02-21       Impact factor: 5.922

3.  Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.

Authors:  E Matthew Morris; Grace M E Meers; Lauren G Koch; Steven L Britton; Justin A Fletcher; Xiaorong Fu; Kartik Shankar; Shawn C Burgess; Jamal A Ibdah; R Scott Rector; John P Thyfault
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-06       Impact factor: 4.310

4.  4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue.

Authors:  Maria Grandoch; Ulrich Flögel; Sam Virtue; Julia K Maier; Tomas Jelenik; Christina Kohlmorgen; Kathrin Feldmann; Yanina Ostendorf; Tamara R Castañeda; Zhou Zhou; Yu Yamaguchi; Emmani B M Nascimento; Vivekananda G Sunkari; Christine Goy; Martina Kinzig; Fritz Sörgel; Paul L Bollyky; Patrick Schrauwen; Hadi Al-Hasani; Michael Roden; Susanne Keipert; Antonio Vidal-Puig; Martin Jastroch; Judith Haendeler; Jens W Fischer
Journal:  Nat Metab       Date:  2019-04-22

Review 5.  Lipid-mediated muscle insulin resistance: different fat, different pathways?

Authors:  Olesja Ritter; Tomas Jelenik; Michael Roden
Journal:  J Mol Med (Berl)       Date:  2015-06-25       Impact factor: 4.599

6.  Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance.

Authors:  Elisa Álvarez Hernández; Sabine Kahl; Anett Seelig; Paul Begovatz; Martin Irmler; Yuliya Kupriyanova; Bettina Nowotny; Peter Nowotny; Christian Herder; Cristina Barosa; Filipa Carvalho; Jan Rozman; Susanne Neschen; John G Jones; Johannes Beckers; Martin Hrabě de Angelis; Michael Roden
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

Review 7.  The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases.

Authors:  Étienne Audet-Walsh; Vincent Giguére
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

8.  Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice.

Authors:  Marie-Christine Simon; Anna Lena Reinbeck; Corinna Wessel; Julia Heindirk; Tomas Jelenik; Kirti Kaul; Juan Arreguin-Cano; Alexander Strom; Michael Blaut; Fredrik Bäckhed; Volker Burkart; Michael Roden
Journal:  J Biol Chem       Date:  2019-12-10       Impact factor: 5.157

Review 9.  The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer.

Authors:  Lakshmipathi Vadlakonda; Meera Indracanti; Suresh K Kalangi; B Meher Gayatri; Navya G Naidu; Aramati B M Reddy
Journal:  J Diabetes Metab Disord       Date:  2020-08-19

10.  Cohort profile: the German Diabetes Study (GDS).

Authors:  Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden
Journal:  Cardiovasc Diabetol       Date:  2016-04-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.